Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 93,305 shares at $66.97 ($6.4M) on 2021-01-19, disclosed to the SEC on 2021-01-21.
Open-market sale of $6.4M ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.97 | 17,634 | $1.2M | 18.5% |
| 2 | $66.97 | 17,634 | $1.2M | 18.5% |
| 3 | $67.75 | 4,581 | $310K | 4.9% |
| 4 | $67.75 | 4,581 | $310K | 4.9% |
| 5 | $69.00 | 6,695 | $462K | 7.2% |
| 6 | $69.74 | 14,201 |
| $990K |
| 15.5% |
| 7 | $69.74 | 14,201 | $990K | 15.5% |
| 8 | $70.66 | 6,889 | $487K | 7.6% |
| 9 | $70.66 | 6,889 | $487K | 7.6% |
| Total | $68.58 avg | 93,305 | $6.4M | 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |